000 | 01130 a2200325 4500 | ||
---|---|---|---|
005 | 20250513211055.0 | ||
264 | 0 | _c20000531 | |
008 | 200005s 0 0 eng d | ||
022 | _a0364-5134 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Seze, J | |
245 | 0 | 0 |
_aEffect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial. _h[electronic resource] |
260 |
_bAnnals of neurology _cMay 2000 |
||
300 |
_a686 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Letter; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 |
_aCytokines _xbiosynthesis |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aGlatiramer Acetate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-10 _xbiosynthesis |
650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
650 | 0 | 4 |
_aPeptides _xpharmacology |
700 | 1 | _aEdan, G | |
700 | 1 | _aLabalette, M | |
700 | 1 | _aDessaint, J P | |
700 | 1 | _aVermersch, P | |
773 | 0 |
_tAnnals of neurology _gvol. 47 _gno. 5 _gp. 686 |
|
999 |
_c10757227 _d10757227 |